论文部分内容阅读
原发性肝癌合并动静脉瘘在临床比较常见,其发生率为22%~60%[1]。介入治疗是目前治疗原发性肝癌,尤其是中晚期肝癌的首选治疗方法,常用肝动脉化疗栓塞术(tran-scatheter arterial chemoembolization,TACE)和射频消融术(radiofrequeney ablation,RFA)等方法治疗,但由于肿瘤存在动
Primary liver cancer with arteriovenous fistula in the clinical more common, the incidence was 22% to 60% [1]. Interventional therapy is currently the first choice for the treatment of primary liver cancer, especially in advanced liver cancer. It is commonly used in the treatment of tran-scatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) Because of the presence of tumors